Status:

COMPLETED

Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsors:

Astellas Pharma Inc

Hoffmann-La Roche

Conditions:

Kidney Diseases

Kidney Transplantation

Eligibility:

All Genders

Up to 21 years

Phase:

PHASE1

PHASE2

Brief Summary

Over the last 40 years, corticosteroids (steroids) have been an important part of drug regimens used to prevent organ rejection and to maintain the immune health of individuals who have received organ...

Detailed Description

Corticosteroids (steroids) have been a cornerstone of immunosuppressive therapy for kidney (renal) transplantation for over 40 years. However, poor growth and bone loss caused by the use of steroids a...

Eligibility Criteria

Inclusion

  • Primary recipient of a kidney transplant
  • Meets site-specific transplant criteria
  • Panel Reactive Antibody (PRA) of 20% or less
  • Willing to use acceptable forms of contraception
  • Parent or guardian willing to provide informed consent, if applicable

Exclusion

  • Previous treatment with steroids within 6 months prior to transplantation
  • Received en-bloc kidney or other kidney that does not meet protocol-specified requirements
  • Received an organ from an human leukocyte antigen (HLA) identical donor or a non-heart-beating donor
  • Received a solid organ other than a kidney
  • Received a bone marrow or hematopoietic stem cell transplant
  • Received a repeat kidney transplant
  • Currently receiving an investigational pharmacologic or biologic agent
  • Human Immunodeficiency virus (HIV) infected or infected with another immunodeficiency virus
  • Hypersensitivity to murine products or the study drugs or their formulations
  • Inability to measure height accurately
  • Pregnant or breastfeeding

Key Trial Info

Start Date :

March 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2010

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT00141037

Start Date

March 1 2004

End Date

November 1 2010

Last Update

November 29 2016

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

University of Alabama - Pediatric Nephrology

Birmingham, Alabama, United States, 35233

2

Maxine Dunitz Children's Health Center Cedars-Sinai

Los Angeles, California, United States, 90048

3

UCLA - Department of Pediatrics, Division of Nephrology

Los Angeles, California, United States, 90095-1752

4

Stanford University Medical Center, Lucile Packard Children's Hospital

Palo Alto, California, United States, 94304